Remote Monitoring for Cancer Patients Undergoing Chemotherapy
This study is testing a new way to monitor cancer patients receiving chemotherapy using an iPhone app called Locus Health and an Apple Watch. The goal is to see if these devices can help detect health problems early, potentially improving your care and reducing healthcare costs. You could be eligible if you are 18 or older, have a solid tumor or blood cancer (hematological malignancy), are starting a new chemotherapy or chemoimmunotherapy treatment for at least four months, and own an Apple iPhone. The study will be considered successful if patients use the app frequently, find the app and watch easy to use, and few patients drop out. The study aims to enroll 100 participants.
- Study design
- This is an observational pilot study involving 100 participants, divided into three groups based on how often they receive queries through the Locus Health iPhone app.
- What's involved
- You will use the Locus Health iPhone App and an Apple Watch during your chemotherapy regimen, for up to 120 days or until your chemotherapy stops.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be monitored for up to 120 days or until their chemotherapy regimen has stopped, whichever is sooner.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
At a glance
Conditions
NCT06106360
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Inova Schar Cancer Institute
Fairfax, Virginiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- John Deeken, MD · PRINCIPAL_INVESTIGATOR · Inova Schar Cancer Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- The Use of Locus Heath iPhone App and the Apple Watch by Participants Undergoing Outpatient Chemotherapy.120 days or until the chemotherapy regimen has stopped, whichever is sooner
The feasibility is determined when 80% of the patients wear the watch at least 70% of the time during waking hours.